


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.44%
+1.47%
+0.51%
-0.54%
HAE
Haemonetics Corporat
$56.83

Login to see Haemonetics Corporat (HAE) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Outperform the market
HAE Price Performance
$60.62 (-6.25%)
$78.81 (-27.89%)
$70.48 (-19.37%)
$59.15 (-3.92%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
HAE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HAE Street Sentiment is extremely bullish and have negative views on the near-term outlook
HAE has Low risk level
Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Dec 18, 2025
Reiterate
Outperform
Mizuho
Nov 21, 2025
Reiterate
Buy
BTIG
Nov 08, 2025
Reiterate
Buy
Needham
Nov 08, 2025
Reiterate
Outperform
Barrington Research
Nov 07, 2025
Reiterate
Buy
BTIG
What is HAE current stock price?
What are HAE stock strengths?
What is HAE Risk Level?
What is HAE market cap and volume?
What is HAE current Stock IQ?
Should I buy HAE stock right now?
Is HAE a Strong Buy right now?
What does a 'Strong Buy' rating mean for HAE?
What does a 'Strong Sell' rating mean for HAE?
What factors influence HAE's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
HAE
Haemonetics Corporat
Current Price
$56.83

HAE Price Performance
$60.62 (-6.25%)
$78.81 (-27.89%)
$70.48 (-19.37%)
$59.15 (-3.92%)
HAE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
HAE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
HAE Street Sentiment is extremely bullish and have negative views on the near-term outlook
HAE has Low risk level
Overall Wall Street Rating
HAE Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market
HAE Trading Signals
HAE is showing oversold conditions with RSI at 26.90 (below 30). This may signal a potential upward reversal or buying opportunity.
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.